Science & Technology
 
Neuronal Nicotinic Receptors (NNRs)

Validated Therapeutic Targets

What are NNRs?


Receptors on nerve cells that act as the "volume knobs" of the nervous system

Where are they?


Throughout the brain and nervous system

What do they do?


Regulate and normalize brain and nervous system function

What do they impact?


Memory, attention, mood, pain, inflammation, movement, and cell survival

What makes them work?


The body's natural activator, acetylcholine (ACh), or potential new drugs that mimic ACh




Which diseases and disorders could NNR-targeted drugs potentially treat?


Alzheimer's disease and other dementias, age associated memory impairment (AAMI), mild cognitive impairment (MCI) and other disorders marked by cognitive impairment, Parkinson's disease, pain, depression, anxiety, schizophrenia and many others

How have NNRs been validated as therapeutic targets?


Well-known NNR activator nicotine has been shown to improve symptoms in many different diseases and disorders, setting the stage for new, more selective NNR-targeted drugs with better efficacy and limited side effects

 

 

©2008 Targacept, Inc. Terms of Use Home Directions Contact Site Map  Go